Clinical Trials Directory

Trials / Completed

CompletedNCT03024307

The Effect of OPCSP on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases

Evaluation of an Outpatient Pharmacy Clinical Services Program on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
242 (actual)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a randomised trial on the efficacy of an Outpatient Pharmacy Clinical Services Program (OPCSP) on adherence and clinical outcomes among patients with rheumatic diseases.The purpose of this study is to evaluate: 1. rates of medication adherence in the OPCSP program compared with usual care in an integrated health care system. 2. total direct costs and clinical outcomes in the OPCSP program compared with usual care in an integrated health care system.

Detailed description

This is a randomised trial on the efficacy of an Outpatient Pharmacy Clinical Services Program (OPCSP) on adherence and clinical outcomes among patients with rheumatic diseases.Three types of rheumatic diseases were included in the study, Systemic lupus erythematosus (SLE), Ankylosing spondylitis (AS), and Rheumatoid Arthritis(RA). The purpose of this study is to evaluate: 1. rates of medication adherence in the OPCSP program compared with usual care in an integrated health care system. 2. total direct costs and clinical outcomes in the OPCSP program compared with usual care in an integrated health care system.

Conditions

Interventions

TypeNameDescription
OTHERpharmacists involved OPCSPThis was an open labelled randomised study. Rheumatic diseases patients were recruited and arbitrarily divided into the intervention group (usual care plus OPCSP) and the non-intervention group (usual care only). Those enrolled in the research were scheduled for follow-up for eight consecutive visits. Improvements in lab results and direct costs were compared longitudinally (pre and post analysis) between the groups.

Timeline

Start date
2017-01-18
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2017-01-18
Last updated
2021-03-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03024307. Inclusion in this directory is not an endorsement.